ARCHIVES

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | March 11, 2005

Download PDF Visit The Full Archive

Related Articles

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

New Breast Cancer Therapies Move Into General Practice; Fisher, Miami Plan Segmental Trials

February 13, 1976

NIH Seeks Comment On Reorg Plan For Oncology Study Sections

April 5, 2002

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

Cancer Act Impact; Mortality Decline; DeVita Tells ACCC

October 9, 1992

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010